Beliefs
The principles that guide what we build, how we allocate capital, and where we believe durable value is created.
The most durable companies are built where multiple disciplines collide. We operate across AI, health, security, and deep-tech — not because diversification is safe, but because breakthroughs happen at boundaries. A pharmaceutical atlas needs AI to map mechanisms. A construction platform needs materials science and regional economics. A privacy tool needs cryptography and machine learning. We build where the problems demand more than one expertise.
Traditional venture capital bets on founders and markets. We bet on our own ability to build. The studio model lets us de-risk ideas before committing capital, share infrastructure across 29+ products, and move faster than standalone startups. Every new product benefits from the battle scars of the last. Shared auth, shared schemas, shared deployment pipelines — the marginal cost of launching product number 30 is a fraction of product number one.
Healthcare is drowning in data and starving for tools. Clinicians need drug interaction maps, not more dashboards. Researchers need IRB-friendly survey platforms, not spreadsheets. Med-spa operators need compliant marketing, not generic website builders. We build vertical tools for specific healthcare workflows — each one solving a problem that horizontal platforms ignore because the market looks too small. It never is.
Every AI deployment creates new attack surface. Every security tool needs AI to keep pace with threats. We sit at this intersection because the two domains are converging whether the market is ready or not. From AI agent scanning to manuscript verification to PII redaction, our security products treat AI as both the threat and the solution. Products built here compound in value as AI adoption accelerates and regulatory pressure increases.
Some of the best businesses are built on problems that require genuine domain expertise — zinc-ion energy storage, construction material pricing intelligence, biological reasoning benchmarks. These markets have high barriers to entry and low competition from generalist startups. We partner with domain experts, build the software layer, and create information advantages that compound over time.
We allocate capital like operators, not like fund managers. Every dollar goes to a product that has already shown signs of traction through internal use. Studio builds get funded from revenue. External capital is reserved for products that have proven product-market fit and need to scale distribution. This means we kill ideas fast, double down on what works, and never build something just because we can.
We build tools for technical operators: products that solve real workflow friction with deterministic features, not AI gimmicks. The best opportunities are markets where incumbents are asleep, regulation is incoming, or the problem is too boring for VC-backed startups to care about. That is exactly where durable businesses are built.
If you're building in AI, health, security, or deep-tech and want a studio partner, we should talk.
Get in Touch